QR Code

Efficacy of the Novel Degludec/Aspart Insulin Co-formulation in Children and Adolescents with Type 1 Diabetes: A Real-life Experience with One Year of IDegAsp Therapy in Poorly Controlled and Non-compliant Patients

INTRODUCTION: To evaluate the efficacy of degludec/aspart (IDegAsp) insulin co-formulation in children and adolescents with poorly controlled type 1 diabetes (T1DM). METHODS: Patients with poorly controlled T1DM on basal-bolus insulin regimes and having compliance problems related to insulin injecti...

Description complète

Enregistré dans:
Auteurs principaux: Tarık Kırkgöz, Mehmet Eltan, Sare Betül Kaygusuz, Zehra Yavaş Abalı, Didem Helvacıoğlu, Tuba Seven Menevşe, Büşra Gürpınar Tosun, Tülay Güran, Abdullah Bereket, Serap Demircioğlu
Format: Artigo
Langue:Inglês
Publié: Pediatric Endocrinology and Diabetes Society 2022-03-01
Collection:JCRPE
Sujets:
type 1 diabetes mellitus
hypoglycemia
diabetic ketoacidosis
co-formulation
insulin degludec
insulin aspart
idegasp
Accès en ligne:https://jag.journalagent.com/z4/download_fulltext.asp?pdir=jcrpe&un=JCRPE-52533
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires